Christopher C Moore Selected Research

Christopher C Moore Research Topics

13	Sepsis (Septicemia) 01/2022 - 01/2008
8	Infections 12/2021 - 08/2013
6	Malaria 02/2021 - 05/2009
3	Inflammation (Inflammations) 08/2013 - 10/2008
2	Hypoxia (Hypoxemia) 06/2022 - 12/2019
2	Communicable Diseases (Infectious Diseases) 12/2021 - 10/2017
2	Shock 10/2017 - 10/2008
2	Coma (Comas) 01/2016 - 05/2013
2	Blastomycosis 12/2015 - 06/2014
2	Bacterial Meningitis 01/2013 - 01/2012
1	Fever (Fevers) 07/2021
1	Neoplasms (Cancer) 07/2021
1	Leukemia 07/2021
1	Meningitis 06/2021
1	Critical Illness (Critically Ill) 06/2021
1	Neutropenia 12/2020
1	Hypertension (High Blood Pressure) 01/2019
1	Septic Shock (Toxic Shock Syndrome) 10/2017
1	Tuberculosis (Tuberculoses) 01/2015
1	Pulmonary Tuberculosis 01/2015
1	Confusion (Bewilderment) 05/2013
1	Viral Meningitis 01/2012
1	Hypoglycemia (Reactive Hypoglycemia) 10/2011
1	Acute Lung Injury 11/2008

4	Anti-Bacterial Agents (Antibiotics)IBA 07/2021 - 11/2009
4	Lactic Acid (Lactate)FDA LinkGeneric 01/2016 - 01/2008
3	Pharmaceutical PreparationsIBA 12/2021 - 01/2015
2	Oxygen (Dioxygen)IBA 06/2022 - 12/2019
2	Antimalarials (Antimalarial Agents)IBA 02/2021 - 01/2017
2	CytokinesIBA 08/2013 - 11/2008
2	LipopolysaccharidesIBA 11/2008 - 10/2008
1	Indicators and Reagents (Reagents)IBA 02/2021
1	PercollIBA 12/2020
1	streptolysin OIBA 12/2020
1	artemisinin (artemisinine)IBA 12/2020
1	GasesIBA 12/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	HDL CholesterolIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Antitubercular AgentsIBA 01/2015
1	posaconazole FDA Link 06/2014
1	Complement System Proteins (Complement)IBA 01/2014
1	Toll-Like Receptor 4IBA 01/2014
1	Macrophage Migration-Inhibitory FactorsIBA 08/2013
1	AcidsIBA 05/2013
1	insulin receptor-related receptor (IRR)IBA 05/2013
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2011
1	ArtemisininsIBA 05/2009
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 05/2009
1	Eukaryotic Translation Initiation Factor 5AIBA 11/2008
1	Liposomes (Liposome)IBA 11/2008
1	Small Interfering RNA (siRNA)IBA 11/2008
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 10/2008
1	ATL 313IBA 10/2008

6	Therapeutics 01/2022 - 11/2008
4	Resuscitation 12/2017 - 07/2012
2	Debridement 12/2021 - 12/2015
2	Knee Replacement Arthroplasty (Total Knee Replacement) 10/2017 - 12/2015
1	Drug Therapy (Chemotherapy) 12/2020
1	Duration of Therapy 10/2017
1	Intranasal Administration 11/2008